|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/545 | |
| G01N 33/50 | |||
| C12N 5/074 | |||
| A61K 38/19 | |||
| A61K 38/20 | |||
| A61P 9/00 |
| (11) | Number of the document | 2539439 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11747958.4 |
| Date of filing the European patent application | 2011-02-23 | |
| (97) | Date of publication of the European application | 2013-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/025846 |
| Date | 2011-02-23 |
| (87) | Number | WO 2011/106365 |
| Date | 2011-09-01 |
| (30) | Number | Date | Country code |
| 308103 P | 2010-02-25 | US |
| (72) |
WODA, Juliana, Megan, US
TING, Anthony, E., US
LEHMAN, Nicholas, A., US
|
| (73) |
ABT Holding Company,
3201 Carnegie Avenue, Cleveland, OH 44115,
US
|
| (54) | MODULATION OF ANGIOGENESIS |
| MODULATION OF ANGIOGENESIS |